Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
Treatment of Adults with Newly Diagnosed Glioblastoma with Partial Brain Radiation Therapy Plus Temozolomide and Chloroquine Followed by Tumor Treating Fields Plus Temozolomide and Chloroquine -- a Pilot Study
Sponsor: Barbara Ann Karmanos Cancer Institute
Terminated
slow accrual
Other terminated trials from Barbara Ann Karmanos Cancer Institute
- Pancreas Adenocarcinoma · Phase PHASE1 · Jul 2025
- Immunotherapy · Phase PHASE1/PHASE2 · Feb 2023
- Metastatic Castration-resistant Prostate Cancer · Phase PHASE3 · Mar 2022
- Castration Levels of Testosterone · Phase PHASE2 · Mar 2022
- Breast Cancer · Phase PHASE2 · Feb 2019
See all terminations from Barbara Ann Karmanos Cancer Institute
This PHASE1 trial investigates Glioblastoma and Gliosarcoma and is currently terminated or withdrawn. Barbara Ann Karmanos Cancer Institute leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Feb 2025 — Present [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Apr 2024 [monthly]
Recruiting PHASE1
▶ Show 6 earlier versions
-
Sep 2022 — Jun 2023 [monthly]
Recruiting PHASE1
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE1
-
Jun 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Barbara Ann Karmanos Cancer Institute
For direct contact, visit the study record on ClinicalTrials.gov .